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Introduction {#sec001}
============

*Wolbachia* releases are being undertaken in *Aedes aegypti* populations both for replacing existing populations with mosquitoes that have a reduced ability to transmit dengue \[[@pone.0225321.ref001], [@pone.0225321.ref002]\] and other arboviruses, and for suppressing mosquito populations directly due to sterility generated by males infected with *Wolbachia* \[[@pone.0225321.ref003]\]. A challenge in implementing *Wolbachia*-based strategies is that a high level of quality control is required for release success. This includes ensuring that source mosquito cultures used for releases remain infected by *Wolbachia*. It is also important to track infection status in release areas (particularly with releases aimed at replacing existing populations by *Wolbachia*-infected populations) given that not all releases are successful and periodic interventions may be needed for others \[[@pone.0225321.ref004], [@pone.0225321.ref005]\]. Successful replacement is dependent on *Wolbachia* frequencies in populations exceeding an unstable equilibrium point \[[@pone.0225321.ref001]\] and potential spread from a release site \[[@pone.0225321.ref006]\].

*Wolbachia* monitoring has been undertaken with a variety of approaches including staining, electron microscopy and PCR with *Wolbachia*-specific primers. For releases where high throughput is desirable, *Wolbachia* detection is currently achieved through qPCR fluorescence-based approaches such as RT/HRM (real time PCR/high resolution melt) such as described by Lee et al. \[[@pone.0225321.ref007]\] which achieves relative quantification of *Wolbachia* on a Roche 480 LightCycler^®^ system allowing samples to be scored in 384-well plates. While this method is efficient and can be used to detect multiple *Wolbachia* strains along with identification of mosquito vectors of disease, it requires expertise and laboratory facilities that are well beyond what is readily available in many developing nations. Each assay also requires a substantial amount of time (around 1.5 h until results are available) as well as a dedicated qPCR machine.

Loop-mediated isothermal amplification (LAMP) is a powerful DNA amplification technique, enabling the detection of trace elements of DNA with high rapidity, sensitivity and accuracy \[[@pone.0225321.ref008]\]. It involves isothermal amplification through the interaction of four to six primers with up to eight target sites. When combined with a polymerase with high displacement activity, two outer primers assist two compound inner primers to form alternating loop structures within the DNA, providing self-primed single-stranded substrates for further inner primer interaction and replication. This process can be further accelerated by the addition of loop primers also targeted to the exposed single-stranded region of the loop \[[@pone.0225321.ref009]\].

This technique has found widespread application primarily in the diagnosis and monitoring of infectious diseases such as malaria \[[@pone.0225321.ref010], [@pone.0225321.ref011]\], West Nile virus \[[@pone.0225321.ref012], [@pone.0225321.ref013]\] and dengue \[[@pone.0225321.ref014]\]. LAMP has also been applied in other contexts including agriculture, quarantine, forensics, and environmental monitoring through DNA \[[@pone.0225321.ref015]\]. In all these contexts, the LAMP technique allows for fast and accurate assays that can be deployed with equivalent sensitivity to traditional PCR methods, but often with much cheaper costs and less technically-demanding deployment--ideal for field contexts and settings where laboratory expertise is limited.

Three LAMP assays have thus far been published for *Wolbachia* monitoring \[[@pone.0225321.ref016]--[@pone.0225321.ref018]\]. Gonçalves et al. (2014) targeted *Wolbachia*'s 16S ribosomal protein sequence, and amplified *Wolbachia* across multiple strains, including *w*AlbB, *w*Mel, and *w*MelPop. A study applying this assay to field samples in Malaysia found that it compared favourably with a standard PCR method for *Wolbachia* detection in *Aedes albopictus* mosquitoes, detecting a higher infected rate than observed with PCR \[[@pone.0225321.ref019]\]. However, it should be noted that this study used an experimental design that did not include the loop primers, which Gonçalves et al. (2014) consider essential to ensure specificity of the assay.

A third *Wolbachia* paper using LAMP \[[@pone.0225321.ref018]\] independently targeted the 16S ribosomal protein sequence. As in the above *Wolbachia* assay \[[@pone.0225321.ref016]\], a range of *Wolbachia* strains were targeted and detected in *Ae*. *albopictus* and *Ae*. *aegypti*. However, an additional assay was also developed specific to *w*AlbB (ordinarily present within *Ae*. *albopictus*) and *w*Pip strain *Wolbachia* surface proteins (*wsp*) \[[@pone.0225321.ref017]\]. This assay originally involved one loop primer and a specific detection method with an additional oligomeric probe designed for presence/absence discrimination of fluorescence by eye. The specific nature of this assay makes it a promising target for adaptation to monitor *Ae*. *aegypti* populations transinfected with *w*AlbB for disease control.

One important development of LAMP techniques has been to quantitatively assess targets (qLAMP) \[[@pone.0225321.ref020]\]. These developments have led to stable linear determinations of products across as many as nine orders of magnitude concentration over a wide range of human and agricultural pathogens \[[@pone.0225321.ref020]--[@pone.0225321.ref023]\]. Such quantitative assessments could be useful for *Wolbachia* monitoring, because a key feature of release success is the frequency of the endosymbiont in field populations. Currently in releases, the *Wolbachia* status of hundreds of mosquitoes is determined at a centralized facility using expensive equipment \[[@pone.0225321.ref001], [@pone.0225321.ref006]\]. In contrast, qLAMP conducted on pools of mosquitoes has the potential to provide rapid and cost-effective estimates of local *Wolbachia* frequencies. When implemented on a device such as the Genie^®^ III, qLAMP assays require minimal training and are highly portable, reducing the load on centralised monitoring laboratories.

Accordingly, the aims of this research were to (a) adapt and extend the assay of Bhadra et al. \[[@pone.0225321.ref017]\] using a *w*AlbB *wsp* primer set as well as an *Ae*. *aegypti ITS1* primer set \[[@pone.0225321.ref024]\] for efficient and specific detection of *w*AlbB-infected *Ae*. *aegypti* mosquitoes in the context of control efforts including those in sub-optimal conditions, (b) compare this method to established qPCR monitoring methods on samples taken from field locations, and (c) develop a quantitative form of the assay for use on pooled mosquito extractions to determine relative *w*AlbB frequencies. The results are expected to be applicable to a variety of projects involving *Wolbachia* within health and agricultural contexts.

Methods {#sec002}
=======

*Aedes aegypti* samples {#sec003}
-----------------------

### Laboratory colonies {#sec004}

*Aedes aegypti* were primarily derived from three laboratory colonies: (a) a *w*AlbB-infected colony with a *w*AlbB strain originating from *Ae*. *albopictus* \[[@pone.0225321.ref025]\], (b) an uninfected colony originating from wild populations in Cairns, Australia, and (c) a *w*Mel-infected colony with a *w*Mel strain originating from *Drosophila melanogaster* \[[@pone.0225321.ref026]\]. The three laboratory colonies of *Ae*. *aegypti* were crossed to mosquitoes of a common Australian background reared in an identical manner to each other, i.e. at 26°C with food provided *ad libitum*. Adults were sacrificed and stored in absolute ethanol before DNA extraction.

### Alternate rearing and storage conditions {#sec005}

*Aedes aegypti* are exposed to a range of environmental conditions in nature, including heat stress and resource competition, which can produce adults of various sizes and with different *Wolbachia* loads \[[@pone.0225321.ref027]\]. We altered rearing conditions to simulate several scenarios affecting size and *Wolbachia* density. Small *w*AlbB-infected adults were produced according to Callahan et al. \[[@pone.0225321.ref028]\] by providing larvae with food *ad libitum* for 3 d and then depriving larvae of food until adulthood. Heat-stressed adults were generated according to Ross et al. \[[@pone.0225321.ref027]\] by holding eggs at a cyclical temperature regime of 30--40°C for one week. Eggs were then hatched and reared under standard conditions to produce adults with a reduced *Wolbachia* density. Field-collected adults are of variable age and may have taken a blood meal; we therefore tested 30 d old adults and 7 d old females that were stored in absolute ethanol at -20°C either immediately or 24 h after feeding on a human volunteer. Six mosquitoes were tested per treatment for these experiments.

We additionally tested the ability of the LAMP assay to detect *w*AlbB when mosquitoes were stored under suboptimal conditions that may be experienced during field sampling. *w*AlbB-infected adults reared in the laboratory were killed by shaking and stored for 1, 2, 3, 5, 10, 20 and 30 d at 26°C or for 10 d at 37°C in open air before storage in absolute ethanol at -20°C. Dead *w*AlbB-infected adults were also stored in water at 26°C for 3 d before transfer to ethanol and -20°C--simulating adults found floating in ovitraps as part of field collections. Six mosquitoes were tested for each scenario, except for 30 d at 26°C and 10 d at 37°C. As these represent the two most extreme scenarios, we tested 18 mosquitoes for each one.

### Malaysian field samples {#sec006}

Malaysian samples were collected from three locations (researchers blinded as to origin) by staff from the Institute for Medical Research, Kuala Lumpur (<https://www.imr.gov.my>), and stored at -20°C in absolute ethanol before extraction. Mosquitoes were collected using ovitraps from two sites in Kuala Lumpur where the release of *w*AlbB-infected mosquitoes with a strain described by Ant et al. \[[@pone.0225321.ref029]\] is currently underway \[[@pone.0225321.ref002]\], as well as one control site where mosquitoes with *Wolbachia* have not been released. Mosquitoes were reared under standard conditions and sacrificed as adults for extraction. DNA was extracted from 24 mosquitoes from each field location for further analysis.

DNA extraction {#sec007}
--------------

For most experiments, individual mosquitoes were extracted by placing them in 200 μL of 0.3 M KOH and incubating tubes at 95°C for five minutes. This is the KOH concentration recommended for GeneWorks' Lyse&Lamp reaction buffer for use on the Genie^®^ III.

For pooled extractions, the quantity of KOH was increased--thus, a pool of 99 uninfected and one *w*AlbB-infected *Ae*. *aegypti* was extracted in 9 mL 0.3 M KOH, with aliquots taken before (i.e. negative control) and after the addition of the lone infected mosquito.

Our standard *Wolbachia* qPCR (LightCycler^®^) methods do not involve KOH. For comparisons between LAMP (Genie^®^ III) and standard qPCR, genomic DNA was extracted using 250 μL of 5% Chelex^®^ 100 Resin (Bio-Rad laboratories, Hercules CA) and 3 μL of Proteinase K (20 mg/ mL) (Roche Diagnostics Australia Pty. Ltd., Castle Hill New South Wales, Australia) solution. Tubes were incubated for 30 minutes at 65°C then for 10 minutes at 90°C. Following Chelex^®^ extraction, an equivalent volume of 0.6 M KOH (Chem-Supply, Gillman, SA, Australia) was added to aliquots taken from each individual to produce final concentrations of 0.3 M KOH for analyses on the Genie^®^ III, with an unadjusted aliquot being used for the qPCR assay.

qPCR assays {#sec008}
-----------

*Aedes aegypti* from the field sampling were tested for *Wolbachia* infection with qPCR according to Lee et al. \[[@pone.0225321.ref007]\] via the Roche LightCycler^®^ 480. Three primer sets were used to amplify markers to confirm quality of mosquito DNA, the *Ae*. *aegypti* species and the presence or absence of the *w*AlbB infection. Crossing point (Cp) values of three consistent replicate runs were averaged to produce the final result. Differences in Cp values between the *Ae*. *aegypti* and *w*AlbB markers were transformed by 2^n^ to produce relative *Wolbachia* density measures.

LAMP assays {#sec009}
-----------

LAMP primers for the *wAlbB wsp* sequence were derived from Bhadra et al. \[[@pone.0225321.ref017]\]. However, their OSD probe for *wsp* was replaced by an additional loop primer to increase detection speed (see [S1 Table](#pone.0225321.s001){ref-type="supplementary-material"}). LAMP primers for the *Ae*. *aegypti ITS1* gene were taken from Schenkel et al. \[[@pone.0225321.ref024]\]. Primers were manufactured according to our specifications by Integrated DNA Technologies Inc. (Coralville, IA, USA) under the standard desalting purification process. Two alternative versions of each primer set were prepared to modify speed characteristics--a five primer and a six primer set. The *wsp* 5-primer set was identical to the original Bhadra primers, whereas the *Ae*. *aegypti ITS1* 5-primer set was constructed by removing the forward loop primer.

Typical LAMP reactions were conducted on a Genie^®^ III machine (OptiGene Limited, Horsham UK)) according to GeneWorks' Lyse&Lamp instructions, using their proprietary ISO-001-LNL Lyse&Lamp buffers. They involved combining 5 μL of a 20-fold dilution of extracted DNA with 20 μL master-mix, itself consisting of 15 μL Lyse&Lamp buffer, as well as enough of each LAMP primer to produce final concentrations of 20 pM FIP & BIP, 10 pM of each loop primer, and 5 pM each F3 & B3 respectively (in a final reaction volume of 25 μL).

Reactions were incubated at 65°C for 20--30 minutes. The Genie^®^ III machine maintains real-time fluorescence detection throughout the incubation. Following amplification, an annealing curve analysis was conducted by reducing temperature by increments from 97 to 78°C in order to confirm the specificity of the amplified products.

Quantitative validation & frequency curves {#sec010}
------------------------------------------

To evaluate the quantitative efficacy of the LAMP primers, three *w*AlbB-infected *Ae*. *aegypti* KOH DNA extractions were first quantified using a Qubit 2.0 fluorometer (Thermo Fisher Scientific), then diluted up to 5,000-fold to form a standard concentration curve for estimating the concentration of the products of the *Ae*. *aegypti ITS1* and *w*AlbB *wsp* LAMP primer sets. LAMP reactions were then run across this curve for both *w*AlbB and *Ae*. *aegypti* primer sets, comparing peak amplification time (T~p~, min) with the log of relative concentration. Following visual inspection, regressions were carried out over the linear sections of that curve using the R function *lm*.

To investigate the ability of qLAMP to detect the relative frequencies of *w*AlbB-infected mosquitoes within a population, pooled DNA mixtures of both *w*AlbB-infected and uninfected individuals were created using laboratory-reared *Ae*. *aegypti*. Each pool was constructed to contain an equal volume of the DNA extract of twenty mosquitoes of mixed sex, but with different numbers of infected and uninfected mosquitoes. Eight frequency levels were constructed (infected/total): 0/20, 1/20, 3/20, 5/20, 8/20, 11/20, 15/20 20/20, with three separately generated pools at each frequency.

To further investigate the sensitivity of *w*AlbB detection in large pools of individuals where very few are infected, an additional pooled mixture was created by combining a single *w*AlbB-infected individual with 99 uninfected in the same extraction.

LAMP reactions targeting both *w*AlbB *wsp* and *Ae*. *aegypti ITS1* regions were then run on these pools, using the previously described concentration regressions to derive relative concentrations of *Wolbachia* and *Ae*. *aegypti* DNA for each pool. The *wAlbB wsp* concentrations were then adjusted for overall mosquito DNA concentration based on *Ae*. *aegypti ITS1* results--i.e. through calculating the ratio of *Wolbachia* concentration to *Ae*. *aegypti* concentration. Visual inspection and regressions were performed on the resulting frequency estimates, testing for goodness of fit with the known frequencies within each sample.

Results and discussion {#sec011}
======================

Primer validation and characterization {#sec012}
--------------------------------------

The *Ae*. *aegypti ITS1* primers from Schenkel et al. \[[@pone.0225321.ref024]\] exhibited a stable annealing point of 92.7°C (S.D. 0.11°C). With fresh reagents (i.e. isothermal buffer within two weeks of resuspension important as buffer decline slows amplification times, biasing quantitative assays), the use of all six primers produced positive detections with peak amplification times (T~p~) ranging between 6 and 12 minutes over a 5,000-fold concentration gradient ([S1 Fig](#pone.0225321.s002){ref-type="supplementary-material"}).

The adapted *w*AlbB *wsp* LAMP primers from Bhadra et al. \[[@pone.0225321.ref017]\] (with an additional loop primer, i.e. with 6 primers) successfully amplified DNA from *w*AlbB-infected laboratory mosquitoes up to ten minutes faster than the Bhadra et al. primers alone, with a stable annealing point of 83.9°C (S.D. 0.17°C). With fresh reagents, these updated primers produced positive detections with *T*~*p*~ values ranging between 7 and 12 minutes over a 5,000-fold concentration gradient ([S1 Fig](#pone.0225321.s002){ref-type="supplementary-material"}). This primer was sensitive enough to detect the presence of *w*AlbB-infection in a 5,000-fold dilution of a KOH-extracted DNA from an *Ae*. *aegypti* individual. We also tested the assay's sensitivity to the presence of infected individuals amongst large pools of uninfected individuals. We could detect a single *w*AlbB-infected *Ae*. *aegypti* among 99 uninfected mosquitoes with a T~p~ of 10 minutes--well within the quantitative bounds for this primer set (see [S1 Fig](#pone.0225321.s002){ref-type="supplementary-material"}).

To investigate the specificity of the modified *w*AlbB *wsp* LAMP primers, we challenged them with *w*Mel-infected *Ae*. *aegypti*. No amplification was seen over a 30-min period in six *w*Mel-infected samples.

When compared with the original 5-primer *w*AlbB *wsp* LAMP assay \[[@pone.0225321.ref017]\], the modified 6-primer assay was substantially faster (compare the concentration curve for 5-primer LAMP in [Fig 1B](#pone.0225321.g001){ref-type="fig"} with the curve for 6-primer (modified) LAMP in [S1 Fig](#pone.0225321.s002){ref-type="supplementary-material"}). This is expressed by a five-minute difference in intercept values for the respective regressions. The modified LAMP primer set we have developed thus represents a rapid, specific, and highly sensitive assay for *w*AlbB detection in *Ae*. *aegypti* mosquitoes.

![Concentration curves for (A) *Ae*. *aegypti ITS1* & (B) *w*AlbB *wsp* LAMP 5-primer sets (i.e. the forward loop primer of each has been removed).\
The horizontal axis shows the natural log of overall extracted DNA in the samples, while the vertical axis shows the peak amplification time (T~p~) for each primer set under fresh reagent conditions. Linear regression lines are shown with 95% confidence intervals shaded.](pone.0225321.g001){#pone.0225321.g001}

Development of qLAMP for *w*AlbB in *Ae*. *aegypti* {#sec013}
---------------------------------------------------

Following KOH extractions, resulting DNA concentrations of three *w*AlbB individuals were first quantified using Qubit, then the samples were diluted up to 5,000-fold to form a standard concentration curve for measuring the *Ae*. *aegypti ITS1* & *w*AlbB *wsp* LAMP primer sets. Concentration was highly correlated with amplification time under 6-primer conditions for each assay ([S1 Fig](#pone.0225321.s002){ref-type="supplementary-material"}); however, for highly precise quantitation these reactions were deemed too fast for the 15-second T~p~ resolution of the current Genie^®^ III software. Accordingly, we repeated the curves on 5-primer LAMP sets, i.e. where the forward loop primer of each group had been removed ([Fig 1](#pone.0225321.g001){ref-type="fig"}).

A regression of 5-primer *Ae*. *aegypti ITS1* T~p~ against the natural logarithm of overall DNA concentration was found to be highly significant (p = 1.2 e-13) with an adjusted R^2^ of 0.918 and a regression coefficient of -1.391 (S.E. 0.086). The regression of the original 5-primer *w*AlbB *wsp* T~p~ against the natural logarithm of overall DNA concentration was also highly significant (p = 1.09 e-08) with an adjusted R^2^ of 0.770 and a regression coefficient of -0.8306 (S.E. 0.094). The reduced R^2^ of *w*AlbB relative to *Ae*. *aegypti* may partly reflect variable concentrations of *w*AlbB within the three mosquitoes used for the curve.

Application of qLAMP to pooled DNA {#sec014}
----------------------------------

The association of *w*AlbB *wsp* to *Ae*. *aegypti ITS1* concentration ratios to known frequency of the infection in DNA from pools of 20 mosquitoes is shown in [Fig 2](#pone.0225321.g002){ref-type="fig"}. The regression was highly significant (p = 1.10e-06) with a regression coefficient of 0.0377 (S.E. 0.0053) and an adjusted R^2^ of 0.7098 --higher than the R^2^ of 0.6091 for a regression of *w*AlbB concentration alone. These patterns suggest that the approach is sufficient for differentiation of *Ae*. *aegypti* with low, medium, or high *w*AlbB infection frequency.

![Ratio of measured *w*AlbB concentrations to *Ae*. *aegypti* concentrations, compared to the actual infection frequency for pools of 20 mosquitoes with differing numbers of *w*AlbB-infected.\
The linear regression line is shown with 95% confidence intervals shaded.](pone.0225321.g002){#pone.0225321.g002}

Effectiveness under conditions of stress or poor storage {#sec015}
--------------------------------------------------------

The *w*AlbB infection was readily detected when dead mosquitoes were stored in air for up to 30 d at 26°C and 10 d at 37°C--an improvement on the original Bhadra assay, which detected *Wolbachia* in only 40% of individuals stored for a week or more at 4°C, and failed to detect *Wolbachia* for individuals scored for a week at 37°C \[[@pone.0225321.ref017]\]. We obtained rapid amplification times for all storage conditions, though times for adults stored in water for 3 d were somewhat impacted ([Fig 3A](#pone.0225321.g003){ref-type="fig"}). Reliable detection of *w*AlbB was also achieved for adults that were aged, blood-fed, heat stressed or nutritionally stressed during development ([Fig 3B](#pone.0225321.g003){ref-type="fig"}). The modified LAMP assay we have developed is therefore robust to both poor storage conditions and low titre of *Wolbachia*. These features are valuable for field contexts such as the continued monitoring of *Wolbachia* releases, as the assay will reliably detect infections in low-titre situations and cope well with samples that have undergone degradation before DNA extraction. Our results suggest *w*AlbB will still be detectable where mosquito bodies have dried out in traps for extended periods (common in adult traps) or where they have been floating in water for some time (common in ovitraps).

![Box plots of *w*AlbB peak amplification times (T~p~) under differing storage conditions or biological states.\
**(A)** Fresh samples compared to varying lengths of dry storage at 26°C, 10 days at 37°C, and 3 days in water. **(B)** Mosquitoes under standard rearing conditions compared to mosquitoes after blood feeding, those undergoing life histories of heat or resource stress, and aged mosquitoes.](pone.0225321.g003){#pone.0225321.g003}

Comparison with established PCR surveillance methods on Malaysian field samples {#sec016}
-------------------------------------------------------------------------------

Over a series of LAMP processes, 24 individuals from each of three Malaysian locations (blindly scored as A, B and C) were tested by both LAMP and LightCycler for presence/absence of *Wolbachia*. For the LAMP results, 22/24 from location A were found to be infected (individuals 4 and 17 absent), and 22/24 from B (individuals 4 and 20 absent). All individuals of location C--which turned out to be a control site where no *Wolbachia* releases have occurred--were scored as uninfected, failing to amplify under LAMP conditions. All results were consistent with those of the qPCR assays ([Table 1](#pone.0225321.t001){ref-type="table"}).

10.1371/journal.pone.0225321.t001

###### Relative performance of qPCR and LAMP assays for *w*AlbB detection in mosquitoes sourced from three sites in Malaysia.

![](pone.0225321.t001){#pone.0225321.t001g}

  Sample   N    Status            Infected (qPCR)   Infected (LAMP)   \% difference
  -------- ---- ----------------- ----------------- ----------------- ---------------
  **A**    24   *w*AlbB release   22                22                0
  **B**    24   *w*AlbB release   22                22                0
  **C**    24   No release        0                 0                 0

When tested with the Genie^®^ III system, the LAMP assays developed in this paper provide a rapid, accurate and robust means of ascertaining *w*AlbB infection status of mosquitoes in field locations without the necessity for complex preparation or the use of developed laboratory facilities. LAMP assays can ascertain *w*AlbB presence/absence in pooled or individual *Ae*. *aegypti* mosquitoes in under 20 minutes' amplification time under a wide variety of environmental or storage conditions, and they can detect infections of 1% or lower in pooled samples, making them suitable for a variety of applications such as rapid monitoring of areas peripheral to a local *Wolbachia* release when monitoring infection spread. Applied to individuals, this *w*AlbB assay shows a similar detection sensitivity and specificity as established qPCR monitoring.

While not sufficiently precise to determine the exact frequency of *Wolbachia* in a sample, this assay when coupled with the *Ae*. *aegypti ITS1* primer set enables approximate quantification of infection frequency within a sample. This has clear applications for monitoring *Wolbachia* deployment for disease control. While an evaluation of release success requires an estimate of *Wolbachia* frequency, approximate estimates may be adequate for many purposes when combined with selective use of more accurate assays. *Wolbachia* could first be characterized as being absent, or as having a low, intermediate or high frequency at a site using a mobile, fast-acting, method as described here. Where an approximate determination of *Wolbachia* frequencies suggest ongoing issues with a release (e.g. where frequencies remain intermediate despite ongoing releases), other more accurate estimates could be obtained. Such a two-tiered monitoring scheme would assist with the scaling of *Wolbachia* releases during an operational phase.

The potential of quantitative LAMP for monitoring and control operations remains to be fully exploited. Until this point, most qLAMP assays have focused on ascertaining the concentrations of pathogens within specific infection contexts (e.g. 14, 21, 30, 31), although studies have considered microorganismal eDNA \[[@pone.0225321.ref014]\], pathogenic viruses in water \[[@pone.0225321.ref030]\] and forensic applications \[[@pone.0225321.ref031]\]. Our study reveals another application--ascertaining the approximate frequency of individuals infected with a symbiotic bacterium in disease-related releases. Other frequency-based applications could include monitoring the spread of disease resistance alleles, infections, and other traits distinguishable by DNA sequence on large scales using pooled DNA. These applications are further supported by the low cost and fast run-times of the assay. Our typical expense for a single individual extracted in 200μL 0.3M KOH run as part of an 8-strip LAMP reaction with the 6-primer *w*AlbB assay is approximately \$3.30 AUD per sample (for comparison, our qPCR assay for *Wolbachia* in *Ae*. *aegypti* is approximately \$1.04 per sample---\$3.12 with three replicates). Additionally, with the use of the Genie^®^ III machine and 5-minute KOH boil in a field context, time from commencing DNA extraction to determination of *Wolbachia* status can realistically be as short as an hour. The highly specific nature of a LAMP assay, owing to its four to six primers required, means it can be easily adapted to diverse targets, provided the primer design is conducted according to best practice.

Supporting information {#sec017}
======================

###### LAMP primers used in this study.

**Top.** *Wolbachia w*AlbB *wsp* LAMP assay (6-primer) \[[@pone.0225321.ref017]\]. **Bottom.** *Aedes aegypti ITS1* LAMP assay (6-primer) \[[@pone.0225321.ref024]\].

(DOCX)

###### 

Click here for additional data file.

###### Concentration curves for (A) *Ae*. *aegypti ITS1* and (B) *w*AlbB *wsp* each with all 6 primers.

Horizontal axes show the natural log of overall extracted DNA in the samples, while vertical axes show the peak amplification time (T~p~) for each primer set under fresh reagent conditions. Linear regression lines are shown with 95% confidence intervals shaded. A regression of 6-primer *Ae*. *aegypti ITS1* T~p~ against the natural logarithm of overall DNA concentration was found to be highly significant (p\<2e-16) with an adjusted R^2^ of 0.919 and a regression coefficient of -0.580 (S.E. 0.029). The regression of 6-primer *w*AlbB *wsp* T~p~ against the natural logarithm of overall DNA concentration was also highly significant (p = 1.27e-13), with an adjusted R^2^ of 0.800 and a regression coefficient of -0.423 (S.E. 0.036). The reduced R^2^ value of *w*AlbB relative to *Ae*. *aegypti* may partly reflect variable concentrations of *w*AlbB within the three mosquitoes used for points along the curve.

(TIF)

###### 

Click here for additional data file.

Malaysian *Ae*. *aegypti* samples were supplied by Dr. Nazni W. Ahmad of the Institute for Medical Research, a division of the Ministry of Health, Malaysia.

10.1371/journal.pone.0225321.r001
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We look forward to receiving your revised manuscript.

Kind regards,

Luciano Andrade Moreira, PhD

Academic Editor

PLOS ONE

Journal Requirements:

1.  When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at

<http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf> and <http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

2\. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: <http://journals.plos.org/plosone/s/supporting-information>.

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Partly

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: N/A

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: Jasper et al. describes the optimisation and validation of a LAMP assay for wAlbB and Aedes aegypti, using primers previously published. The assay was able to detect both targets in samples from laboratory and the field, even in some simulated extreme conditions. The present study brings new findings regarding the ability to detect Wolbachia but I have some comments that must be considered, as follow:

1\) The number of mosquitoes tested in each of the extreme conditions (i.e. 30 d old vs 7d old; immediately or 24hs after bloodmeal) was really low, being only 6 (Lane 137). Why was it not tested in a larger number of samples? Those extreme conditions that may happen in the field are so hard to reproduce in the lab. I would suggest to test more mosquitoes.

2\) In methods, for different storage conditions, the number of mosquitoes tested should be mentioned. (lane 137-142).

3\) The description of figures 1A, 1B, S1A and S1B are confusing along the manuscript. The use of two different LAMP reactions (5 or 6 primers) should be better described in methods and results and discussion at "primer validation and characterization". It is not clear if supplementary figures were used with 5 or 6 primers. This information should be added to the legend of each figure to make it easier to be interpreted.

4\) Are there figures to confirm the findings presented in lanes 235-239 (the results when 1 infected mosquito was tested with 99 uninfected and also the absence of amplification over 30min of reaction)? If so, the figure should be mentioned or I would recommend to say the data was not shown.

Also, the use of a pool of 99 uninfected mosquitoes with 1 infected should be better addressed along the manuscript.

5\) The data obtained when performing the qLAMP with pooled DNA was too variable within the groups. i.e. when you have 8 infected samples, some of the pools have similar concentration when you have 12 or 15 infected out of 20. The number of samples tested was very low (n= 3), so I believe this big variation might be due to it. I would suggest running with a bigger number of samples.

Would you consider using pools in large scale releases for Wolbachia monitoring? How would you discriminate if you have 8 or 15 mosquitoes infected in a pool? An accurate method to calculate Wolbachia frequency is essential to plan releases in order to reach a population 100% Wolb-infected. I would suggest to mention this limitation in the discussion.

6)In the discussion, the LAMP assay optimised in this study was considered low cost and fast (lane 332). What is the cost per sample if you run both genes by qPCR?

Reviewer \#2: This study describes the validation of two previously published sets of LAMP primers, one specific to wAlbB (and wPip) Wolbachia wsp gene and the other specific for Aedes aegypti ITS gene. While the authors did not modify the published ITS primer set, they modified the published Wolbachia assay by not using the probe that was used in the original paper for accurate visual 'yes/no' assay readout. Instead the authors designed a second loop primer to bind to the loop region used by the probe in order to speed up the LAMP reaction. In very well thought out experiments, the authors then validated performance characteristics of the primer sets with mosquitoes that were reared and stored in the lab under different conditions designed to mimic scenarios that would likely be encountered with field collected mosquitoes. They also directly compared performance with qPCR using field collected mosquitoes. This work would be of value to the research community because such independent validation of LAMP assays reported in literature provides necessary confirmation and confidence that these assays would indeed be successful diagnostic tools for vector surveillance under a variety of application conditions and variables.

The paper is well written and documented, however a few questions should be addressed:

1\. The authors state that their aim was to improve the previously reported Wolbachia assay and that they do so by removing the sequence-specific probe used in the original assay and replacing it with a second loop primer, which as expected increases the speed of the reaction by \~5-10 min. It is debatable that this change can be considered an improvement. While assay speed was modestly increased, readout mode was changed from a sequence-specific signal (hallmark of most gold standard diagnostic applications, for instance TaqMan qPCR) to a non-sequence-specific signaling method. Moreover, this change results in an overall increase in assay cost probably due to the use of proprietary LAMP master mixes and a precision Genie II machine that costs close to \$18,000. The authors should refer to their alteration of the Wolbachia assay only as a modification and not as an improvement.

2\. Although the authors mention that they are using previously published LAMP assays either directly (ITS) or with a slight modification of adding one loop primer (wsp), their statements later on in the manuscript, such as "The LAMP primer set we have developed" in line 244 and "The LAMP assay we have developed" in line 290 appear misleading. These statements should be modified appropriately to indicate that in the current work the authors have validated previously published assays and made modifications that can increase speed, albeit at the cost of eliminating sequence-specific visual readout.

3\. In Figure 1 the authors should indicate how many samples were tested for each DNA concentration. It appears that although there is a general trend between decreasing template amount and increasing Tp, at many positions in the standard curves lower template concentrations are being amplified faster than higher template concentrations. The authors should address how this lack of exact correlation between template amount and Tp, which is quite common for continuous amplification methods such as LAMP, would affect the accuracy of any qLAMP-based quantitations.

4\. One of the most interesting notions in the manuscript was the attempt to standardize determination of Wolbachia infection frequency in a population of mosquitoes by comparing concentrations of mosquito-specific marker (ITS) with that of the Wolbachia marker. However, as shown in Figure 2, there is considerable variation. This might partly be due to the inherent inaccuracy in qLAMP quantitation. It could also be, as the authors suggest, individual to individual variation. The authors should test more mosquitoes in each of their low, mid, and high infection groups to see if this variation can be reduced to achieve more accurate prediction.

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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Response to reviewers

Reviewer 1.

1\. Too few samples

We have increased the sample sizes for individuals in the 30 days at 26C and the 10 days at 37C categories (our most extreme, preservation-wise) to 18 to fill the gap. (See updated Figure 3).

2\. List number mosquitoes tested in methods

These have been added (Lines 143-144)

3\. Clarify 5 and 6 primer LAMP usage

Methods and results have been updated to reference construction of 5 and 6-primer sets (Lines 184-187, 236).

Figure S1 has also been updated to clearly communicate the use of 6 primers.

4\. Better address use of pool of 99 uninfected mosquitoes

We do not present these results in figures because the only data to present are amplification times which are shown in the text.

'Along the manuscript', Lines 215-217 were updated to more clearly describe the motivation for the 99 pooled uninfected experiment. Lines 242-245 were also updated to more clearly distinguish the pooled sample experiment from the other experiments described in that section.

5\. qLAMP with pooled DNA is imprecise

We thank the reviewer for their constructive feedback. It is likely low sample sizes contribute to the variable nature of the quantitation, but we also appreciate there are limits of detection resolution. Nevertheless we believe pooled detection methods are a viable strategy for monitoring large-scale Wolbachia releases---if carefully deployed as a component of an integrated monitoring scheme. Specifically we propose a two-tier system where LAMP quantitations are used in-field to rapidly quantify approximate frequencies across a large number of sites, with a central reference lab performing qPCR to follow up on key sites as identified through LAMP results. Rolling out of this process would benefit from an in-principle field demonstration and further standardisation and calibration.

We have updated our discussion to further acknowledge the quantitative imprecision of this pooled method, and to more extensively discuss how it could be used as part of a monitoring scheme (lines 330-341).

6\. cost of qPCR needs to be added

The cost has been added at lines 353-354

Reviewer 2.

1\. Inappropriate use of the language of "improvement" on previous assay

We thank the reviewer for drawing our attention to issues around the language used to describe what is novel about our work with the previously published (Bhadra) primers & assay process.

The 5-10 minute difference in amplification time assumes the use of our reagents & the Genie-III machine, which are integral to our assay. The original Bhadra assay calls for an amplification time of 90 minutes (compare under 25 minutes for ours). The trade-offs in terms of sequence specificity can be considered minimal for most purposes -- the lack of a TaqMan-like probe is balanced by data output by Genie-III about amplification time and the annealing temperature of the product. This can be used to distinguish true amplifications from spurious amplifications -- adequate for the majority of routine field monitoring uses.

Furthermore, our assay exceeds benchmarks of the Bhadra assay in some areas. Most importantly there is a substantial improvement in the ability to detect Wolbachia in mosquitoes stored at higher temperatures (such as in BG traps which are often only checked after several days). Bhadra et. al. detected only 40% of Wolbachia infected mosquitoes stored at 4C (and none after week 2), and zero detection for samples stored at 37C. We detect Wolbachia in 100% of individuals stored at 26C for 1 month, and stored at 37C for 10 days. And we detected wAlbB in 100% of mosquitoes left in water for 3 days prior to extraction.

As the reviewer has suggested, there will likely be many applications where the Bhadra assay remains more useful. Thus we agree that unqualified language of 'improvement' may not be appropriate. However, as we have outlined, our modifications do exceed the original assay on many metrics that are significant in field release monitoring. We have altered the reference to improving the Bhadra assay to instead reference 'adapting and extending' (line 105). We have also included some discussion explicitly comparing the two assays (lines 292-294).

2\. "we have developed" neglects dependence on previous study

To clarify the intention behind these phrases, we have altered "The LAMP primer set we have developed" to read "The modified LAMP primer set we have developed" (lines 252-253), and altered "The LAMP assay we have developed" to read, "The modified LAMP assay we have developed (lines 298-299).

3\. Scatter in curve and lack of exact correlation

We provide information about the samples used for concentration curves in the methods (lines 200-207). We also quantify the strength of correlation through the statistical regression results reported in lines 271-277, as well as through the 95% confidence intervals included in the Figure 1 graph.

We include further discussion about the imprecision issue in connection with the pooled DNA quantification (Reviewer 1 Q. 5, Reviewer 2 Q. 4).

4\. Infection frequency determination is imprecise

We agree that there is some imprecision associated with frequency determination.. Per our response to reviewer \#1's 5th comment, we have acknowledged this in our discussion (lines 330-341).
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Dear Dr. Jasper,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.
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If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

With kind regards,

Luciano Andrade Moreira, PhD

Academic Editor
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Additional Editor Comments (optional):

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#1: All comments have been addressed

Reviewer \#2: All comments have been addressed

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: N/A

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: (No Response)

Reviewer \#2: (No Response)
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7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).
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Reviewer \#2: No
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